comparemela.com

Latest Breaking News On - While novo nordisk - Page 1 : comparemela.com

3 Monster Stocks in the Making You Can Buy Right Now

2 Obesity Treatment Stocks Morgan Stanley Likes More than Novo Nordisk

While Novo Nordisk's Wegovy currently dominates the obesity treatment market, Morgan Stanley sees more upside potential for LLY and AZN stocks going forward.

Global Access to Weight-Loss Treatments: Indian Pharma Giants Eye Affordable Wegovy Alternatives Amid Rising Demand

While Novo Nordisk A/S NVO faces challenges in meeting the global demand for its highly sought-after weight-loss treatment, Wegovy, Indian drugmakers see an…

Indian pharma cos speed up anti-obesity drug development amidst high demand and Ozempic sales surge

Sun Pharma, Dr. Reddy's, Lupin, Torrent, and Zydus Cadila progressing obesity drug candidates in response to rising demand. Notable developments include Sun Pharma's Phase 1 studies and Dr. Reddy’s Laboratories' permission for a semaglutide bioequivalence study

Bayer, Novo separately opt to discontinue their Aliqopa, Levemir

Bayer, Novo separately opt to discontinue their Aliqopa, Levemir
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.